Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-008063
Filing Date
2024-11-14
Accepted
2024-11-14 13:03:21
Documents
74
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR SEPT 2024 aclarion_i10q-093024.htm   iXBRL 10-Q 1161757
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER aclarion_ex3101.htm EX-31.1 10259
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER aclarion_ex3102.htm EX-31.2 10482
4 CERTIFICATION aclarion_ex3201.htm EX-32.1 3682
5 CERTIFICATION aclarion_ex3202.htm EX-32.2 3704
  Complete submission text file 0001683168-24-008063.txt   5979419

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE acon-20240930.xsd EX-101.SCH 56080
7 XBRL CALCULATION FILE acon-20240930_cal.xml EX-101.CAL 52326
8 XBRL DEFINITION FILE acon-20240930_def.xml EX-101.DEF 244097
9 XBRL LABEL FILE acon-20240930_lab.xml EX-101.LAB 396871
10 XBRL PRESENTATION FILE acon-20240930_pre.xml EX-101.PRE 353553
76 EXTRACTED XBRL INSTANCE DOCUMENT aclarion_i10q-093024_htm.xml XML 794989
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41358 | Film No.: 241459676
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)